期刊文献+

妇科良性疾病患者外周血HE4水平的分布状况研究 被引量:5

Serum Level of the Ovarian Cancer Biomarker HE4 in Benign Gynecologic Dieases
下载PDF
导出
摘要 目的:研究妇科良性疾病患者外周血人附睾蛋白4(HE4)水平的分布情况,为临床对妇科良恶性疾病的鉴别诊断提供一定的帮助。方法:依据临床诊断和手术病理检查结果,选取940例妇科良性疾病患者,采用化学发光法测定患者外周血HE4水平,研究妇科良性疾病患者中HE4水平与疾病种类和年龄的关系,数据分析使用SPSS 19.0软件进行统计学分析。结果:妇科良性疾病患者外周血HE4的测定值均低于140 pmol/L,最高测定值97.32 pmol/L。妇科良性疾病患者外周血中HE4水平随着年龄的增长而升高,所有研究对象外周血HE4水平的第95%百分位数水平是65.44 pmol/L,<40岁患者外周血HE4水平的第95%百分位数水平61.14pmol/L,≥40岁患者外周血HE4水平的第95%百分位数水平66.39 pmol/L。结论:妇科良性疾病患者外周血HE4水平随着年龄的增长而升高,利用HE4进行良恶性疾病的诊断时应考虑到患者年龄的因素。 Objective:The aim of the study was to analyze the serum level of HE4 in benign gynecologic diseases contributing to the differential diagnosis between benign gynecologic diseases and ovarian cancer. Methods :940 women with benign gynecologic diseases were enrolled in this study,including 106 with ovarian benign tumor,95 with ovarian cyst, 157 with teratoma, 252 with endometriosis, 235 with uterine fibroids, 77 with adenomyosis and 18 with hydrosalpinx. Serum HE4 levels in 940 patients were examined and analyzed according to disease type and age. Upper 95th percentiles were determined for the range in benign gyneco- logic diseases. Results :The highest value of HE4 in benign gynecologic diseases was 97. 32 pmol/L. Over the age of 40-year significant elevation in HE4 level emerged with advancing age. The upper 95th percentile for HE4 level was 65.44 pmol/L for all of patients, 61.14 pmol/L for patients less than 40-year old, and 66.39 pmol/L for patients over 40-yearold. Conclusions:Serum HE4 level varies significantly on the basis of age in benign gynecologic diseases. The variations should be considered in the differential diagnosis between benign gynecologic diseases and ovarian cancer.
出处 《实用妇产科杂志》 CAS CSCD 北大核心 2014年第1期46-49,共4页 Journal of Practical Obstetrics and Gynecology
关键词 肿瘤标志物 人附睾蛋白4 妇科良性疾病 年龄 Biomarker Human epididymis protein 4 Benign gynecologic disorders Age
  • 相关文献

参考文献8

  • 1Granato T, Midulla C, Longo F, et al. Role of HE4, CA 72-4 and CA125 in monitoring ovarian cancer [ J ]. Tumour biology, 2012,33 ( 5 ) : 1335 - 1339.
  • 2Moore RG, Miller MC, Steinhoff MM, et al. Serum HE4 levels are less frequently elevated than CA lZ5 in women with benign gynecologic dis- orders[J]. Am J Obstet Gynecol,2012,206(4) :351. e1 -8.
  • 3Hellstrtim I, Raycraft J, Hayden-Ledbetter M, et al. The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma[ J ]. Cancer Res,2003,63 ( 13 ) :3695 - 3700.
  • 4董丽,昌晓红,叶雪,朱丽荣,赵旸,田莉,程洪艳,李小平,张虹,廖秦平,付天云,成夜霞,崔恒.血清人附睾分泌蛋白4和CA125水平检测在卵巢恶性肿瘤中的诊断价值[J].中华妇产科杂志,2008,43(12):931-936. 被引量:98
  • 5Galgano M, Hampton G, Frierson HJ. Comprehensive analysis of HE4 expression in normal and malignant human tissues [ J ]. Mod Pathol, 2006,19(6) :847 -853.
  • 6Moore RG, Miller MC, Eklund EE, et al. Serum levels of the ovarian cancer biomarker HFA are decreased in pregnancy and increase with age[J]. Am J Obstet Gyneeol,2012,206(4) :349. e1 -7.
  • 7Park Y,Kim Y,Lee EY,et al. Reference ranges for HE4 and CA125 in a large Asian population by automated assays and diagnostic perform- ances for ovarian cancer [ J]. Int J Cancer, 2012, 130 ( 5 ) : 1136 -1144.
  • 8蔡斌,刘雪莲,杨懿霞,席晓薇,丰有吉.913例健康体检女性血清HE4水平分布的初步观察[J].实用妇产科杂志,2012,28(12):1045-1047. 被引量:9

二级参考文献9

  • 1Gadducci A, Cosio S, Carpi A, et al. Serum tumor markers in the management of ovarian, endometrial and cervical cancer. Biomed Pharmacother,2004,58 : 24 -38.
  • 2Meyer T, Rustin GJ. Role of tumour markers in monitoring epithelial ovarian cancer. Br J Cancer,2000,82 : 1535-1538.
  • 3Hellstrom I, Raycraft J, Hayden-Ledbetter M, et al. The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma. Cancer Res, 2003,63 : 3695 -3700.
  • 4Israeli O, Goldring-Aviram A, Rienstein S, et al. In sihco chromosomal clustering of genes displaying altered expression patterns in ovarian cancer. Cancer Genet Cytogenet,2005 ,160 :35- 42.
  • 5Drapkin R, von Horsten HH, Lin Y, et al. Human epididymis protein 4 ( HE4 ) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas. Cancer Res, 2005, 65:2162-2169.
  • 6Kirchhoff C, Habben I, Ivell R, et al. A major human epididymisspecific cDNA encodes a protein with sequence homology to extracellular proteinase inhibitors. Biol Reprod, 1991,45: 350- 357.
  • 7Moore RG, Brown AK, Miller MC, et al. The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass. Gynecol Oncol,2008,108:402-408.
  • 8胡晓舟,崔丽艳,张捷.健康人群血清HE4水平参考区间的初步探讨[J].中华检验医学杂志,2009,32(12):1376-1378. 被引量:27
  • 9刘润幸.使用SPSS作多变量观察值的ROC曲线分析[J].中国公共卫生,2003,19(9):1151-1152. 被引量:128

共引文献105

同被引文献29

  • 1梁海平.妇科护理安全隐患的分析及对策研究[J].健康之路,2014,13(10):229.
  • 2Kirchhoff C, Haben I, Ilvell R, et al. A major human epidid- lymis- specific cDNA encodes a protein with sequence ho- mology to extracellular proteinase inhibitors [ J]. Biol Re- prod, 1991,45 (2) : 350 - 357.
  • 3Gao L, Cheng HY, Dong L, et al. The role of HE4 in ovarian cancer inhibiting tumour Cell proliferiation and metastasis [J]. J Jnt Med Res,2011,39(5) : 1645 -1660.
  • 4Angioli R, Plotti F, Capriglione S, et ah The role of novel hio- marker HE4 in endometrial cancer :a case control prospec- tive study[ J ]. Tumor Biol,2013.34 ( 1 ) :571 - 576.
  • 5Bignotti E, RagtrLxli M, Zanotti L, et al . Diagonstic and pmgnestic impact of nectm HE -4 detection in endomerial immuniuma palensa [J].Br J Cancer, 2011,104 (9) : 1418-1425.
  • 6Zanotti L, Bignotti E, Calan S, et al. Human opididymis pro- rein4 as a serum marker for diagnosis of endomentrial and prediction of clinical outcome [ J ]. Clin Chem Lab Med, 2012,50(12) :2189 -2198.
  • 7Kalogera E, Scholler N, Powess C, et al. Con'elation of serum HE4 with tumor size and myometrial invasion in endometrial cancer [ J ]. Gynecol Oncol, 2012,124 ( 2 ) : 270 - 275.
  • 8Urban K,Thorpe J, Karlan BY, et al . Interpretation of sin- gle and serial measures of HE - 4 and CA125 in asympto- matic women at high risk for ovarian cancer[ J]. Cancer Ep- idemial Biomark Prey,2012,21 ( 11 ) :2087 -2094.
  • 9胡晓舟,崔丽艳,张捷.健康人群血清HE4水平参考区间的初步探讨[J].中华检验医学杂志,2009,32(12):1376-1378. 被引量:27
  • 10徐春琳,杨艳华,王惠兰,左宏玲,王英,路晓琳.血清人附睾蛋白4对卵巢上皮性癌的诊断价值[J].中国实用妇科与产科杂志,2010,26(9):684-686. 被引量:17

引证文献5

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部